Stock Information
Kymera Therapeutics Inc (KYMR)
Ticker Symbol: KYMR
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $9,656.22 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): -3.24
Revenue (TTM): $1.07 M
Dividend Yield: N/A
ROE: -21.5%
Latest News
-
Stifel Maintains Buy on Kymera Therapeutics, Raises Price Target to $152
Tue, Sep 22, 2026 6:43 AM
Key Financials
Financial data not available